Abiopharma

🔍 Coler Thomas (Executive)

Company: QUAKER CHEMICAL CORP (KWR)

Report Date: 2026-03-15

Detailed Transactions and Holdings:

• Acquired 666 shares of Common Stock (Direct)
  Date: 2026-03-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,107.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 882 shares of Common Stock (Direct)
  Date: 2026-03-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,989.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 30 shares of Common Stock (Direct)
  Date: 2026-03-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,019.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 541 shares of Common Stock at $118.45 per share (Direct)
  Date: 2026-03-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,478.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 666 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 667.00 | transaction_form_type: 4 | Footnotes: F1, F4, F4
• Sold 882 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,764.00 | transaction_form_type: 4 | Footnotes: F1, F5, F5
• Sold 30 shares of Dividend Equivalent Rights (Derivative)
  Date: 2026-03-15 | Code: M | Expires: 2026-03-15 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F2, F2
• Acquired 2,870 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,870.00 | transaction_form_type: 4 | Footnotes: F6, F6, F6

Footnotes:

• F1: Restricted stock units (RSUs) convert into common stock on a one-for-one basis.
• F2: Dividend equivalent rights (DERs) accrued on reporting person's RSUs granted on June 15, 2024 and March 15, 2025. The rights accrued when and as dividends were paid on KWR common stock. This Form 4 reports the settlement of DERs in connection with the second installment of the 2024 RSU grant and the first installment of the 2025 RSU grant, each vesting on March 15, 2026. Each DER was the economic equivalent of one share of KWR common stock.
• F3: Shares surrendered by reporting person to satisfy withholding tax obligations upon the partial vesting of certain restricted stock units previously granted under the Company's Long-Term Performance Incentive Plan.
• F4: On June 15, 2024, the reporting person was granted 1,999 time-based RSUs, vesting in three annual installments beginning on March 15, 2025.
• F5: On March 15, 2025, the reporting person was granted 2,646 time-based RSUs, vesting in three annual installments beginning on March 15, 2026.
• F6: Time-based RSUs granted under the Company's Long-Term Performance Incentive Plan, which will vest in three annual installments beginning on March 15, 2027. Each RSU represents a contingent right to receive one share of KWR common stock and DERs accrue with respect to these RSUs when and as dividends are paid on KWR common stock.